Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Aseptic (non-bacterial or viral [except varicella zoster*] meningitis; also see enterovirus) | |||
Bacterial, gram negative enteric, in neonates | |||
Fungal** |
**Alert the Microbiology Laboratory (353-1268) prior to submitting specimens for culture from patients with suspected or confirmed Coccidiodes meningitis |
||
Haemophilus influenzae (known or suspected) |
Until 24 hrs after initiation of effective therapy |
||
Listeria monocytogenes | |||
Neisseria meningitidis (known or suspected) |
Until 24 hrs after initiation of effective therapy |
||
Pneumococcal (Streptococcus pneumoniae) | |||
Tuberculosis*** |
***Patient should be examined for evidence of current (active) pulmonary tuberculosis. If evidence exists, see Tuberculosis below for additional isolations. |
||
Other diagnosed bacterial | |||
Varicella, disseminated (e.g., meningitis + rash) | |||
Unknown etiology |
Until etiology is determined or Neisseria meningitidis is ruled out |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Adult and Pediatric hematology/oncology/BMT patients: All other patients: Duration of illness |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Please continue isolation until the case is discussed with Infection Prevention. Isolation will be needed until lesions have crusted, those crusts have separated, and a fresh layer of healthy skin has formed underneath. |
Immediately contact HEIP. Refer to the UCSF Mpox Tip Sheet. Additional resources, including for testing, are available on the Mpox web page. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Carbapenem, cefepime or ceftazidime resistant Pseudomonas aeruginosa- carbapenemase gene positive |
Duration of hospitalization and upon readmission. |
Isolation may not be removed. The following carbapenemase genes are tested: KPC, NDM, OXA-48, VIM, IMP-1. |
|
ESBL producer and carbapenemase gene positive |
Duration of hospitalization and upon readmission. |
Isolation may not be removed. The following carbapenemase genes are tested: KPC, NDM, OXA-48, VIM, IMP-1. |
|
ESBL producer and NO carbapenemase gene | |||
Carbapenem Resistant Enterobacteriaceae- non carbapenemase gene positive (non CP- CRE) | |||
Carbapenem Resistant Enterobacteriaceae- carbapenemase gene positive (CP-CRE) |
Duration of hospitalization and upon readmission. |
Isolation may not be removed. The following carbapenemase genes are tested: KPC, NDM, OXA-48, VIM, IMP-1. |
|
Enterococcus, vancomycin resistant (VRE) |
If drainage cannot be contained by dressing, add Contact + Standard Isolation |
||
Staphylococcus aureus, nafcillin / methicillin resistant | |||
Staphylococcus aureus, vancomycin intermediate/resistant |
Duration of hospitalization and upon readmission. |
Discontinuation will be determined by Infection Prevention on a case by case basis. |
|
Carbapenem Resistant Acinetobacter- carbapenemase gene positive |
Duration of hospitalization and upon readmission. |
Isolation may not be removed. The following carbapenemase genes are tested: KPC, NDM, OXA-48, VIM, IMP-1. |